Cargando…

Linking hypothetical knowledge patterns to disease molecular signatures for biomarker discovery in Alzheimer’s disease

BACKGROUND: A number of compelling candidate Alzheimer’s biomarkers remain buried within the literature. Indeed, there should be a systematic effort towards gathering this information through approaches that mine publicly available data and substantiate supporting evidence through disease modeling m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Malhotra, Ashutosh, Younesi, Erfan, Bagewadi, Shweta, Hofmann-Apitius, Martin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4256903/ https://www.ncbi.nlm.nih.gov/pubmed/25484918 http://dx.doi.org/10.1186/s13073-014-0097-z

Ejemplares similares

Exploring novel mechanistic insights in Alzheimer’s disease by assessing reliability of protein interactions
por: Malhotra, Ashutosh, et al.
Publicado: (2015)

Biomarker-guided translation of brain imaging into disease pathway models
por: Younesi, Erfan, et al.
Publicado: (2013)

NeuroRDF: semantic integration of highly curated data to prioritize biomarker candidates in Alzheimer's disease
por: Iyappan, Anandhi, et al.
Publicado: (2016)

‘HypothesisFinder:’ A Strategy for the Detection of Speculative Statements in Scientific Text
por: Malhotra, Ashutosh, et al.
Publicado: (2013)

From integrative disease modeling to predictive, preventive, personalized and participatory (P4) medicine
por: Younesi, Erfan, et al.
Publicado: (2013)

From integrative disease modeling to predictive, preventive, personalized and participatory (P4) medicine
por: Younesi, Erfan, et al.
Publicado: (2014)

PDON: Parkinson’s disease ontology for representation and modeling of the Parkinson’s disease knowledge domain
por: Younesi, Erfan, et al.
Publicado: (2015)

Bioinformatics Mining and Modeling Methods for the Identification of Disease Mechanisms in Neurodegenerative Disorders
por: Hofmann-Apitius, Martin, et al.
Publicado: (2015)

A network model of genomic hormone interactions underlying dementia and its translational validation through serendipitous off-target effect
por: Younesi, Erfan, et al.
Publicado: (2013)

Analytical Strategy to Prioritize Alzheimer’s Disease Candidate Genes in Gene Regulatory Networks Using Public Expression Data
por: Kawalia, Shweta Bagewadi, et al.
Publicado: (2017)

Systems approach for the selection of micro-RNAs as therapeutic biomarkers of anti-EGFR monoclonal antibody treatment in colorectal cancer
por: Deyati, Avisek, et al.
Publicado: (2015)

Using Drugs as Molecular Probes: A Computational Chemical Biology Approach in Neurodegenerative Diseases
por: Emon, Mohammad Asif Emran Khan, et al.
Publicado: (2017)

Mining biomarker information in biomedical literature
por: Younesi, Erfan, et al.
Publicado: (2012)

HuPSON: the human physiology simulation ontology
por: Gündel, Michaela, et al.
Publicado: (2013)

Detecting miRNA Mentions and Relations in Biomedical Literature
por: Bagewadi, Shweta, et al.
Publicado: (2015)

Of Mice and Men: Comparative Analysis of Neuro-Inflammatory Mechanisms in Human and Mouse Using Cause-and-Effect Models
por: Kodamullil, Alpha Tom, et al.
Publicado: (2017)

Predictors of Willingness to Enroll in Hypothetical Alzheimer Disease Biomarker Studies that Disclose Personal Results
por: Erickson, Claire M., et al.
Publicado: (2022)

NeuroTransDB: highly curated and structured transcriptomic metadata for neurodegenerative diseases
por: Bagewadi, Shweta, et al.
Publicado: (2015)

Neuroimaging Feature Terminology: A Controlled Terminology for the Annotation of Brain Imaging Features
por: Iyappan, Anandhi, et al.
Publicado: (2017)

Comparison and aggregation of event sequences across ten cohorts to describe the consensus biomarker evolution in Alzheimer’s disease
por: Golriz Khatami, Sepehr, et al.
Publicado: (2022)

Data-Driven Modeling of Knowledge Assemblies in Understanding Comorbidity Between Type 2 Diabetes Mellitus and Alzheimer’s Disease
por: Karki, Reagon, et al.
Publicado: (2020)

Biomarker Gene Signature Discovery Integrating Network Knowledge
por: Cun, Yupeng, et al.
Publicado: (2012)

Towards a global investigation of transcriptomic signatures through co-expression networks and pathway knowledge for the identification of disease mechanisms
por: Figueiredo, Rebeca Queiroz, et al.
Publicado: (2021)

CSEO – the Cigarette Smoke Exposure Ontology
por: Younesi, Erfan, et al.
Publicado: (2014)

Challenges of Integrative Disease Modeling in Alzheimer's Disease
por: Golriz Khatami, Sepehr, et al.
Publicado: (2020)

Evaluating the Alzheimer's disease data landscape
por: Birkenbihl, Colin, et al.
Publicado: (2020)

Quantifying and Describing the Natural History and Costs of Alzheimer’s Disease and Effects of Hypothetical Interventions
por: Wimo, Anders, et al.
Publicado: (2020)

Neurological Mechanisms of Animal-Assisted Intervention in Alzheimer’s Disease: A Hypothetical Review
por: Kim, Sujin, et al.
Publicado: (2021)

Discovery of Novel Biomarkers for Alzheimer's Disease from Blood
por: Long, Jintao, et al.
Publicado: (2016)

ADataViewer: exploring semantically harmonized Alzheimer’s disease cohort datasets
por: Salimi, Yasamin, et al.
Publicado: (2022)

The "Alzheimer's disease signature": potential perspectives for novel biomarkers
por: Davinelli, Sergio, et al.
Publicado: (2011)

Deep undepleted human serum proteome profiling toward biomarker discovery for Alzheimer’s disease
por: Dey, Kaushik Kumar, et al.
Publicado: (2019)

Comorbidity Analysis between Alzheimer’s Disease and Type 2 Diabetes Mellitus (T2DM) Based on Shared Pathways and the Role of T2DM Drugs
por: Karki, Reagon, et al.
Publicado: (2017)

Forecasting individual progression trajectories in Alzheimer’s disease
por: Maheux, Etienne, et al.
Publicado: (2023)

ANMerge: A Comprehensive and Accessible Alzheimer’s Disease Patient-Level Dataset
por: Birkenbihl, Colin, et al.
Publicado: (2021)

The discovery of Alzheimer's disease
por: Hippius, Hanns, et al.
Publicado: (2003)

PEMT: a patent enrichment tool for drug discovery
por: Gadiya, Yojana, et al.
Publicado: (2022)

Biomarker-Based Signature of Alzheimer’s Disease in Pre-MCI Individuals
por: Chipi, Elena, et al.
Publicado: (2019)

DNA methylation signature of human hippocampus in Alzheimer’s disease is linked to neurogenesis
por: Altuna, Miren, et al.
Publicado: (2019)

An Alzheimer’s Disease-Derived Biomarker Signature Identifies Parkinson’s Disease Patients with Dementia
por: Berlyand, Yosef, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_g3tjuirdn06k58o21sp8ida3rg